Synergistic Combination Chemotherapy of Camptothecin and Floxuridine Through Self�Assembly of Amphiphilic Drug�Drug Conjugate

Synergistic Combination Chemotherapy of Camptothecin and Floxuridine Through Self�Assembly of Amphiphilic Drug�Drug Conjugate

Synergistic Combination Chemotherapy of Camptothecin and Floxuridine through Self-assembly of Amphiphilic Drug-Drug Conjugate Minxi Hu, Ping Huang, Yao Wang, Yue Su, Linzhu Zhou, Xinyuan Zhu,* and Deyue Yan* School of Chemistry and Chemical Engineering, Shanghai Key Lab of Electrical Insulation and Thermal Aging, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China * Correspondence to: [email protected]; [email protected]. Fax: +86-21-54741297 Table of Contents Supplementary Figures 1 Figure S1: H NMR spectra of CPT and CPT-COOH in DMSO-d6. Figure S2: FTIR spectra of CPT, FUDR, and CPT-FUDR conjugate. Figure S3: (A) UV/Vis spectra of CPT, FUDR and CPT-FUDR conjugate in acetonitrile. (B) Fluorescence emission spectra of CPT (λ ex = 360 nm, λ em = 430 nm) and CPT-FUDR conjugate (λ ex = 360 nm, λ em = 426 nm) in DMSO. Figure S4: The UV absorbance of DPH in an aqueous solution of CPT-FUDR nanoparticles with various concentrations. The CAC value of CPT-FUDR nanoparticles is about 15 µM. Figure S5: Influence of storage on (A) diameter (the diameter measured in Day 1 was set as control, and the data are presented as ratios to the control) and (B) PDI of CPT-FUDR nanoparticles with the extension of time in water. Figure S6: (A)Total ion chromatography (TIC) of CPT and CPT-FUDR . (B, C) Extracted ion chromatography (EIC) of CPT-FUDR (m/z = 693.1835, (M+H +)) and CPT (m/z = 349.1165, (M+H +)). The retention time of CPT-FUDR and CPT is 3.92 and 3.79 min, respectively. Figure S7: (A) Total ion chromatography (TIC) of the cell extracts. (B, C) Extracted ion chromatography (EIC) of CPT-FUDR (m/z = 693.1853, (M+H +)) and FUDR (m/z = 349.1205, (M+H +)). The retention time of CPT-FUDR and CPT is 3.93, and 3.80 min, respectively. Figure S8: Flow cytometry histogram profiles of HT-29 cells treated with CPT-FUDR nanoparticles containing core-encapsulated Nile red for 30 min, 2 h and 4 h. 1 Figure S1. H NMR spectra of CPT and CPT-COOH in DMSO-d6. Figure S2. FTIR spectra of CPT, FUDR, and CPT-FUDR conjugate. Figure S3 . (A) UV/Vis spectra of CPT, FUDR and CPT-FUDR conjugate in acetonitrile. (B) Fluorescence emission spectra of CPT (λ ex = 360 nm, λ em = 430 nm) and CPT-FUDR conjugate (λ ex = 360 nm, λ em = 426 nm) in DMSO. Figure S4. The UV absorbance of DPH in an aqueous solution of CPT-FUDR nanoparticles with various concentrations. The CAC value of CPT-FUDR nanoparticles is about 15 µM. Figure S5. Influence of storage on (A) diameter (the diameter measured in Day 1 was set as control, and the data are presented as ratios to the control) and (B) PDI of CPT-FUDR nanoparticles with the extension of time in water. Figure S6. (A)Total ion chromatography (TIC) of CPT and CPT-FUDR. (B, C) Extracted ion chromatography (EIC) of CPT-FUDR (m/z = 693.1835, (M+H +)) and CPT (m/z = 349.1165, (M+H +)). The retention time of CPT-FUDR and CPT is 3.92 and 3.79 min, respectively. Figure S7. (A) Total ion chromatography (TIC) of the cell extracts. (B, C) Extracted ion chromatography (EIC) of CPT-FUDR (m/z = 693.1853, (M+H +)) and FUDR (m/z = 349.1205, (M+H +)). The retention time of CPT-FUDR and CPT is 3.93, and 3.80 min, respectively. Figure S8. Flow cytometry histogram profiles of HT-29 cells treated with CPT-FUDR nanoparticles containing core-encapsulated Nile red for 30 min, 2 h and 4 h. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us